NovaBay Pharmaceuticals

(NYSEMKT) NBY

Current Price$1.64

Market Cap$43.66M

Since IPO (2007)-100%

5 Year-100%

1 Year-14%

1 Month+4%

NovaBay Pharmaceuticals Financials at a Glance

Market Cap

$43.66M

Revenue (TTM)

$0.00

Net Income (TTM)

$522.59M

EPS (TTM)

$-7.43

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$1.64

Volume

69,990

Open

$1.73

Price

$1.64

Volume

69,990

Open

$1.73

Previous Close

$1.64

Daily Range

$1.60 - $1.73

52-Week Range

$1.11 - $99.75

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$1.64

Volume

69,990

Open

$1.73

Previous Close

$1.64

Daily Range

$1.60 - $1.73

52-Week Range

$1.11 - $99.75

NBY News

Avoid This Drug Stock

CAPS' Weekly Top Stock IdeaJan 19, 2012

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovaBay Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Michael Kazley

Website

www.novabay.com

Headquarters

EmeryVille, CA 94608, US

NBY Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-2%

Net Income Margin

212%

Return on Equity

-588%

Return on Capital

-3%

Return on Assets

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

0.92%

Stock Overview

Market Cap

$43.66M

Shares Outstanding

26.63M

Volume

69.99K

Avg. Volume

403.89K

Financials (TTM)

Gross Profit

$140.00K

Operating Income

$7.58M

EBITDA

$7.45M

Operating Cash Flow

$8.43M

Capital Expenditure

$0.00

Free Cash Flow

$8.43M

Cash & ST Invst.

$7.96M

Total Debt

$776.00K

NovaBay Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$43.66M

N/A

Market Cap/Employee

$3.36M

N/A

Employees

N/A

Net Income

$552.40M

+7102.1%

EBITDA

$22.29M

+780.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$17.77M

+142.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$166.00K

-74.0%

Short Term Debt

$471.00K

-3.3%

Return on Assets

2.91%

N/A

Return on Invested Capital

-2.99%

N/A

Free Cash Flow

$1.80M

-36.3%

Operating Cash Flow

$1.80M

-36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.67-0.06%

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.71-0.42%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.47-1.98%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.78-1.78%

PMCBPharmaCyte Biotech, Inc.

PMCBPharmaCyte Biotech, Inc.$0.80-15.38%

ADXNAddex Therapeutics Ltd

ADXNAddex Therapeutics Ltd$7.10+0.00%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$5.79-0.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About NBY

What is the current price of NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals is trading at $1.64 per share.

What is the 52-week range for NovaBay Pharmaceuticals?

Over the past 52 weeks, NovaBay Pharmaceuticals has traded between $1.11 and $99.75.

How much debt does NovaBay Pharmaceuticals have?

As of the most recent reporting period, NovaBay Pharmaceuticals reported total debt of $637,000.

How much cash does NovaBay Pharmaceuticals have on hand?

NovaBay Pharmaceuticals reported $18.41M in cash and cash equivalents in its most recent financial results.

What is NovaBay Pharmaceuticals’s dividend yield?

NovaBay Pharmaceuticals does not currently have a dividend yield.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Financials at a Glance

NBY News

Avoid This Drug Stock

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NovaBay Pharmaceuticals

NBY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NovaBay Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NBY

What is the current price of NovaBay Pharmaceuticals?

What is the 52-week range for NovaBay Pharmaceuticals?

How much debt does NovaBay Pharmaceuticals have?

How much cash does NovaBay Pharmaceuticals have on hand?

What is NovaBay Pharmaceuticals’s dividend yield?

Premium Investing Services